Project Details
Description
ZEUS - Effects of ziltivekimab versus placebo on cardiovascular outcomes in participants with established atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation
| Status | Active |
|---|---|
| Effective start/end date | 6/1/21 → 6/30/25 |
Funding
- NOVO NORDISK, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.